115 related articles for article (PubMed ID: 36906375)
1. Corrigendum to "Elimusertib (BAY1895344), a novel ATR inhibitor, demonstrates in vivo activity in ATRX mutated models of uterine leiomyosarcoma".
Harold J; Bellone S; Manavell DD; Mutlu L; McNamara B; Hartwich TMP; Zipponi M; Yang-Hartwich Y; Demirkiran C; Verzosa MSZ; Choi J; Dong W; Buza N; Hui P; Altwerger G; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Schwartz PE; Santin AD
Gynecol Oncol; 2023 Mar; 170():334. PubMed ID: 36906375
[No Abstract] [Full Text] [Related]
2. Elimusertib (BAY1895344), a novel ATR inhibitor, demonstrates in vivo activity in ATRX mutated models of uterine leiomyosarcoma.
Harold J; Bellone S; Manavella DD; Mutlu L; McNamara B; Hartwich TMP; Zipponi M; Yang-Hartwich Y; Demirkiran C; Verzosa MS; Choi J; Dong W; Buza N; Hui P; Altwerger G; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Schwartz PE; Santin AD
Gynecol Oncol; 2023 Jan; 168():157-165. PubMed ID: 36442427
[TBL] [Abstract][Full Text] [Related]
3. Exome Sequencing of Uterine Leiomyosarcomas Identifies Frequent Mutations in TP53, ATRX, and MED12.
Mäkinen N; Aavikko M; Heikkinen T; Taipale M; Taipale J; Koivisto-Korander R; Bützow R; Vahteristo P
PLoS Genet; 2016 Feb; 12(2):e1005850. PubMed ID: 26891131
[TBL] [Abstract][Full Text] [Related]
4. Nuclear pCHK1 as a potential biomarker of increased sensitivity to ATR inhibition.
Sundararajan V; Tan TZ; Lim D; Peng Y; Wengner AM; Ngoi NYL; Jeyasekharan AD; Tan DSP
J Pathol; 2023 Feb; 259(2):194-204. PubMed ID: 36373784
[TBL] [Abstract][Full Text] [Related]
5. Targeted next-generation sequencing of cancer genes identified frequent TP53 and ATRX mutations in leiomyosarcoma.
Yang CY; Liau JY; Huang WJ; Chang YT; Chang MC; Lee JC; Tsai JH; Su YN; Hung CC; Jeng YM
Am J Transl Res; 2015; 7(10):2072-81. PubMed ID: 26692951
[TBL] [Abstract][Full Text] [Related]
6. Loss of ATRX/DAXX expression and alternative lengthening of telomeres in uterine leiomyomas.
Ahvenainen TV; Mäkinen NM; von Nandelstadh P; Vahteristo MEA; Pasanen AM; Bützow RC; Vahteristo PM
Cancer; 2018 Dec; 124(24):4650-4656. PubMed ID: 30423196
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Vulnerability to ATR Inhibition in Concurrent
Yuan M; Eberhart CG; Pratilas CA; Blakeley JO; Davis C; Stojanova M; Reilly K; Meeker AK; Heaphy CM; Rodriguez FJ
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740680
[TBL] [Abstract][Full Text] [Related]
8. Novel and Highly Potent ATR Inhibitor M4344 Kills Cancer Cells With Replication Stress, and Enhances the Chemotherapeutic Activity of Widely Used DNA Damaging Agents.
Jo U; Senatorov IS; Zimmermann A; Saha LK; Murai Y; Kim SH; Rajapakse VN; Elloumi F; Takahashi N; Schultz CW; Thomas A; Zenke FT; Pommier Y
Mol Cancer Ther; 2021 Aug; 20(8):1431-1441. PubMed ID: 34045232
[TBL] [Abstract][Full Text] [Related]
9. Loss of ATRX and DAXX expression identifies poor prognosis for smooth muscle tumours of uncertain malignant potential and early stage uterine leiomyosarcoma.
Slatter TL; Hsia H; Samaranayaka A; Sykes P; Clow WB; Devenish CJ; Sutton T; Royds JA; Ip PP; Cheung AN; Hung NA
J Pathol Clin Res; 2015 Apr; 1(2):95-105. PubMed ID: 27499896
[TBL] [Abstract][Full Text] [Related]
10. Loss of ATRX confers DNA repair defects and PARP inhibitor sensitivity.
Garbarino J; Eckroate J; Sundaram RK; Jensen RB; Bindra RS
Transl Oncol; 2021 Sep; 14(9):101147. PubMed ID: 34118569
[TBL] [Abstract][Full Text] [Related]
11. Defective survival of proliferating Sertoli cells and androgen receptor function in a mouse model of the ATR-X syndrome.
Bagheri-Fam S; Argentaro A; Svingen T; Combes AN; Sinclair AH; Koopman P; Harley VR
Hum Mol Genet; 2011 Jun; 20(11):2213-24. PubMed ID: 21427128
[TBL] [Abstract][Full Text] [Related]
12. Leiomyosarcoma with alternative lengthening of telomeres is associated with aggressive histologic features, loss of ATRX expression, and poor clinical outcome.
Liau JY; Tsai JH; Jeng YM; Lee JC; Hsu HH; Yang CY
Am J Surg Pathol; 2015 Feb; 39(2):236-44. PubMed ID: 25229770
[TBL] [Abstract][Full Text] [Related]
13. Retinal interneuron survival requires non-cell-autonomous Atrx activity.
Lagali PS; Medina CF; Zhao BY; Yan K; Baker AN; Coupland SG; Tsilfidis C; Wallace VA; Picketts DJ
Hum Mol Genet; 2016 Nov; 25(21):4787-4803. PubMed ID: 28173139
[TBL] [Abstract][Full Text] [Related]
14. Copper ions are novel therapeutic agents for uterine leiomyosarcoma.
Kakuda M; Matsuzaki S; Ueda Y; Shiomi M; Matsuzaki S; Kimura T; Fujita M; Egawa-Takata T; Kobayashi E; Serada S; Yoshino K; Naka T; Kimura T
Am J Obstet Gynecol; 2020 Jan; 222(1):64.e1-64.e16. PubMed ID: 31351063
[TBL] [Abstract][Full Text] [Related]
15. ATR inhibition enables complete tumour regression in ALK-driven NB mouse models.
Szydzik J; Lind DE; Arefin B; Kurhe Y; Umapathy G; Siaw JT; Claeys A; Gabre JL; Van den Eynden J; Hallberg B; Palmer RH
Nat Commun; 2021 Nov; 12(1):6813. PubMed ID: 34819497
[TBL] [Abstract][Full Text] [Related]
16. Targeting ATR as Cancer Therapy: A new era for synthetic lethality and synergistic combinations?
Bradbury A; Hall S; Curtin N; Drew Y
Pharmacol Ther; 2020 Mar; 207():107450. PubMed ID: 31836456
[TBL] [Abstract][Full Text] [Related]
17. A novel transcription regulatory complex containing death domain-associated protein and the ATR-X syndrome protein.
Tang J; Wu S; Liu H; Stratt R; Barak OG; Shiekhattar R; Picketts DJ; Yang X
J Biol Chem; 2004 May; 279(19):20369-77. PubMed ID: 14990586
[TBL] [Abstract][Full Text] [Related]
18. Genomic Database Analysis of Uterine Leiomyosarcoma Mutational Profile.
Astolfi A; Nannini M; Indio V; Schipani A; Rizzo A; Perrone AM; De Iaco P; Pirini MG; De Leo A; Urbini M; Secchiero P; Pantaleo MA
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32751892
[TBL] [Abstract][Full Text] [Related]
19. Ataxia telangiectasia and Rad3-related inhibitors and cancer therapy: where we stand.
Mei L; Zhang J; He K; Zhang J
J Hematol Oncol; 2019 Apr; 12(1):43. PubMed ID: 31018854
[TBL] [Abstract][Full Text] [Related]
20. A novel missense mutation in ATRX uncovered in a Yemeni family leads to alpha-thalassemia/mental retardation syndrome without alpha-thalassemia.
Hamzeh AR; Nair P; Mohamed M; Saif F; Tawfiq N; Al-Ali MT; Bastaki F
Ir J Med Sci; 2017 May; 186(2):333-337. PubMed ID: 26860117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
